| Profit & Loss account of Aurobindo Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| INCOME |
|
|
|
|
|
|
| Revenue From Operations [Gross] |
31,378.13 |
28,704.50 |
24,617.13 |
23,366.55 |
24,557.94 |
|
| Less: Excise/Sevice Tax/Other Levies |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue From Operations [Net] |
31,378.13 |
28,704.50 |
24,617.13 |
23,366.55 |
24,557.94 |
|
| Total Operating Revenues |
31,723.73 |
29,001.87 |
24,855.38 |
23,455.49 |
24,774.62 |
|
| Other Income |
621.85 |
557.38 |
290.59 |
320.35 |
380.85 |
|
| Total Revenue |
32,345.58 |
29,559.25 |
25,145.97 |
23,775.84 |
25,155.47 |
|
| EXPENSES |
|
|
|
|
|
|
| Cost Of Materials Consumed |
10,736.76 |
10,776.14 |
9,652.51 |
7,371.83 |
8,317.26 |
|
| Purchase Of Stock-In Trade |
2,887.11 |
2,772.93 |
2,050.43 |
1,951.77 |
2,315.42 |
|
| Operating And Direct Expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Changes In Inventories Of FGWIP And Stock In Trade |
-597.63 |
-946.17 |
-409.68 |
816.68 |
-730.21 |
|
| Employee Benefit Expenses |
4,475.62 |
3,922.94 |
3,522.25 |
3,450.92 |
3,535.02 |
|
| Finance Costs |
457.24 |
289.71 |
140.48 |
48.64 |
74.49 |
|
| Depreciation And Amortisation Expenses |
1,649.42 |
1,521.66 |
1,244.58 |
1,126.52 |
1,055.39 |
|
| Other Expenses |
7,639.08 |
6,633.03 |
6,321.23 |
5,477.52 |
6,003.73 |
|
| Total Expenses |
27,247.60 |
24,970.24 |
22,521.80 |
20,243.88 |
20,571.10 |
|
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax |
5,097.98 |
4,589.01 |
2,624.17 |
3,531.96 |
4,584.37 |
|
| Exceptional Items |
0.00 |
-191.86 |
0.00 |
-127.97 |
2,814.58 |
|
| Profit/Loss Before Tax |
5,097.98 |
4,397.15 |
2,624.17 |
3,403.99 |
7,398.95 |
|
| Tax Expenses-Continued Operations |
|
|
|
|
|
|
| Current Tax |
1,699.98 |
1,777.54 |
1,071.48 |
662.82 |
2,321.82 |
|
| Less: MAT Credit Entitlement |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Deferred Tax |
-117.26 |
-566.52 |
-386.63 |
62.81 |
-312.05 |
|
| Other Direct Taxes |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Total Tax Expenses |
1,582.72 |
1,211.02 |
684.85 |
725.63 |
2,009.77 |
|
| Profit/Loss After Tax And Before ExtraOrdinary Items |
3,515.26 |
3,186.13 |
1,939.32 |
2,678.36 |
5,389.18 |
|
| Profit/Loss From Continuing Operations |
3,515.26 |
3,186.13 |
1,939.32 |
2,678.36 |
5,389.18 |
|
| Profit/Loss For The Period |
3,515.26 |
3,186.13 |
1,939.32 |
2,678.36 |
5,389.18 |
|
| Minority Interest |
2.31 |
4.00 |
-0.15 |
1.04 |
1.02 |
|
| Consolidated Profit/Loss After MI And Associates |
3,485.88 |
3,172.97 |
1,927.50 |
2,648.15 |
5,334.84 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| EARNINGS PER SHARE |
|
|
|
|
|
|
| Basic EPS (Rs.) |
60.00 |
54.00 |
33.00 |
45.00 |
91.00 |
|
| Diluted EPS (Rs.) |
60.00 |
54.00 |
33.00 |
45.00 |
91.00 |
|
| DIVIDEND AND DIVIDEND PERCENTAGE |
|
|
|
|
|
|
| Equity Share Dividend |
0.00 |
0.00 |
439.45 |
263.67 |
234.38 |
|
| Tax On Dividend |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
